Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Dermatology

Skin cancer screening guidelines can seem confusing – three skin cancer researchers explain when to consider getting checked

Protecting oneself from the summer sun and its damaging ultraviolet rays is often not straightforward. And public health messaging around when and how to be screened for skin cancer has become somewhat confusing.

The Conversation

Multi-drug therapy helped reduce leprosy cases in the country, says dermatologist

Keloji Hanumanthayya, Professor of Dermatology at Sri Devaraj Urs Medical College, Tamaka, Kolar, has said that multi-drug therapy (MDT) recommended by World Health Organisation has played a crucial role in the reduction of leprosy cases in India.

The Hindu

'Doctors wouldn't diagnose my son with strep A as symptoms look different on Black skin'

Last year's worrying scarlet fever outbreak in Britain posed a particular problem for Black parents who weren't told about what to look for on their children's skin

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

10 common skin conditions

Here's a countdown of 10 common skin conditions, some benign and others life-threatening.

LiveScience

Institute offers booster shots

The Institute of Dermatology is offering a Covid-19 vaccination service using the Gen2-Bivalent Pfizer vaccine at its headquarters on Ratchawithi Road.

Bangkok Post

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Tribune News Service

The AI medical device powering a new era of skin cancer care across the NHS

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Do COVID-19 vaccines help keep you from going bald?

The COVID-19 vaccines can help keep you from getting the nasty virus, missing many days of work or school, and ending up in the hospital or the graveyard.

Tribune News Service

Torrent Pharma to acquire Curatio Healthcare for Rs 2,000 crore

AHMEDABAD: Gujarat-based pharmaceutical major, Torrent Pharmaceuticals on Tuesday announced it will acquire dermatology firm, Curatio Healthcare (I) Private Limited for Rs 2,000 crore.

The Times of India

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga

NOVN: EPI Revenue Trends Are Strong

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

Benzinga

Mayo Clinic Minute: Learning the ABCDEs of melanoma

Melanoma is a type of skin cancer that develops in cells that produce your skin's pigment. Regular skin checks can help you identify the warning signs and differentiate melanoma from noncancerous skin formations, according to the American Academy of Dermatology.

Tribune News Service

Is collagen worth taking? Scientists reveal the ideal method for building the protein

Our body naturally produces collagen — it's also a 2 billion dollar supplement industry. Inverse spoke to experts from the fields of orthopedics, nutrition, sports, and dermatology to separate collagen fact from fiction.

Inverse

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

NOVN: First EPI Sales

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.